Prothena to Report Third Quarter 2026 Financial Results on November 5 October 29, 2026 Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its third quarter and first nine months of 2026 financial results on Thursday, November 5, 2026, after the close of the U.S. financial markets. Consistent with past practice, [...]
AB InBev Reports Third Quarter 2026 Results October 29, 2026 Solid top- and bottom-line performance with volume growth, revenue up 4.9% and Underlying EPS up 22%
Everest Reports Third Quarter 2026 Results October 28, 2026 Annualized Total Shareholder Return of 14.2% Strengthened Casualty Reinsurance Reserves Repurchased $474 million of Common Shares During the Quarter
Smurfit Westrock Reports Third Quarter 2026 Results October 28, 2026 Smurfit Westrock plc (NYSE: SW) today announced the financial results for the third quarter ended September 30, 2026. Key Points: Net Sales of $8,161 million Net Income of $219 million, with a Net Income Margin of 2.7% Adjusted EBITDA1 of $1,205 million, with an Adjusted EBITDA Margin1 of 14.8% Net Cash Provided by Operating Activities [...]
Logitech Announces Q2 Fiscal Year 2027 Results October 27, 2026 Second Quarter Marks Company’s Eleventh Consecutive Quarter of Growth
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026 October 27, 2026 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on November 3, 2026. Compass management will host a conference call at [...]
Allegion (NYSE: ALLE) Reports Q3-2026 Financial Results October 22, 2026 High-Single Digit Revenue Growth, Strength in Americas Non-Residential; Raising Full-Year 2026 Outlook Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $2.59, up 18.8% compared with $2.18; Adjusted EPS of $2.60, up 13.0% compared with $2.30 Revenues of $1,172.6 million, up 9.6% on a reported basis and up 7.2% on an organic basis Operating margin of 24.3%, compared with 21.8%; Adjusted operating margin of 24.7%, compared with 24.1%
LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November October 21, 2026 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that members of the Company’s Executive Leadership Team will provide general business updates during fireside chats at the four following November healthcare conferences: UBS Global Healthcare Conference on Mon., Nov. 9, from 11-11:35 a.m. EST in Palm Beach, Fla. 8th Annual Wolfe Research Healthcare [...]
Smurfit Westrock to Announce 2026 Third Quarter Results on October 28, 2026 October 21, 2026 Smurfit Westrock plc (NYSE:SW) plans to release its financial results for the third quarter ended September 30, 2026 on Wednesday, October 28, 2026 at 6:30 am ET (10:30 am GMT). Smurfit Westrock’s earnings release and related materials will be available at smurfitwestrock.com At 7:30 am ET (11:30 am GMT) on the same day, Smurfit Westrock’s [...]
Bureau Veritas: Double Digit Total Revenue Growth in the Third Quarter of 2026 October 21, 2026 Organic revenue growth sequential improvement; 2026 outlook confirmed